Back to Journals » Psoriasis: Targets and Therapy » Volume 12

Psoriasis: Targets and Therapy

ISSN: 2230-326X


Archive: Volume 12, 2022

Assessment of Vitamin D Level in Patients with Psoriasis and Its Correlation with Disease Severity: A Case–Control Study

Pokharel R, Agrawal S, Pandey P, Lamsal M

Psoriasis: Targets and Therapy 2022, 12:251-258

Published Date: 13 September 2022

Towards Personalized Medicine in Psoriasis: Current Progress

Camela E, Potestio L, Ruggiero A, Ocampo-Garza SS, Fabbrocini G, Megna M

Psoriasis: Targets and Therapy 2022, 12:231-250

Published Date: 1 September 2022

Therapeutic Inertia in the Management of Psoriasis: A Quantitative Survey Among Indian Dermatologists and Patients

Rajagopalan M, Dogra S, Godse K, Kar BR, Kotla SK, Neema S, Saraswat A, Shah SD, Madnani N, Sardesai V, Sekhri R, Varma S, Arora S, Kawatra P

Psoriasis: Targets and Therapy 2022, 12:221-230

Published Date: 25 August 2022

Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis

Gisondi P, Bellinato F, Maurelli M, Geat D, Zabotti A, McGonagle D, Girolomoni G

Psoriasis: Targets and Therapy 2022, 12:213-220

Published Date: 10 August 2022

Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study

Megna M, Potestio L, Fabbrocini G, Ruggiero A

Psoriasis: Targets and Therapy 2022, 12:205-212

Published Date: 14 July 2022

Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study

Megna M, Fornaro L, Potestio L, Luciano MA, Nocerino M, Delfino M, Guarino M, Fabbrocini G, Camela E

Psoriasis: Targets and Therapy 2022, 12:199-204

Published Date: 9 July 2022

Psoriasis and Exercise: A Review

Yeroushalmi S, Hakimi M, Chung M, Bartholomew E, Bhutani T, Liao W

Psoriasis: Targets and Therapy 2022, 12:189-197

Published Date: 2 July 2022

Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience

Rosés Gibert P, de la Torre Gomar FJ, Saenz Aguirre A, Gimeno Castillo J, González Pérez R

Psoriasis: Targets and Therapy 2022, 12:177-185

Published Date: 29 June 2022

Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives

Chung M, Bartholomew E, Yeroushalmi S, Hakimi M, Bhutani T, Liao W

Psoriasis: Targets and Therapy 2022, 12:151-176

Published Date: 22 June 2022

Comorbidity in Adult Psoriasis: Considerations for the Clinician

Daugaard C, Iversen L, Hjuler KF

Psoriasis: Targets and Therapy 2022, 12:139-150

Published Date: 10 June 2022

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge

Ruggiero A, Potestio L, Camela E, Fabbrocini G, Megna M

Psoriasis: Targets and Therapy 2022, 12:127-137

Published Date: 8 June 2022

Economic Burden of Generalized Pustular Psoriasis in Sweden: A Population-Based Register Study

Löfvendahl S, Norlin JM, Schmitt-Egenolf M

Psoriasis: Targets and Therapy 2022, 12:89-98

Published Date: 5 May 2022

The Effect of Lifestyle Changes on Disease Severity and Quality of Life in Patients with Plaque Psoriasis: A Narrative Review

van Acht MR, van den Reek JMPA, de Jong EMGJ, Seyger MMB

Psoriasis: Targets and Therapy 2022, 12:35-51

Published Date: 9 April 2022